BoomBoom
08-21-2016, 06:51 AM
http://s2.1pic.org/files/2016/08/15/ee6f95c2ce54e14d85d3.jpg
Pediatric Psychopharmacology For Primary Care by Dr. Mark A Riddle M.D.
2015 | ISBN: 1581102755 | English | 225 pages | PDF | 5 MB
Confidently prescribe, monitor, and manage medications for childhood mental health disorders.
This game-changing resource from the American Academy of Pediatrics (AAP) arms you with a unique strategic approach-plus practice-tested, condition-specific treatment recommendations.
Free bonus digital tool! Get instant answers on specific conditions and medications from your desktop or mobile device!
Evidence-based conceptual framework
A clear, straightforward methodology-based on current research and clinical experience-defines discrete levels of psychotropic agents and spells out level-specific roles and responsibilities.
Group 1:Medications FDA-approved for youth for ADHD, anxiety, and depression-disorders for which pediatric primary care providers commonly initiate treatment and assume prescribing and monitoring responsibilities.
Administration and management information for each drug agent includes:
Rationale for use
Evidence supporting efficacy and safety
Initial dosing and subsequent adjustments
Measuring therapeutic success
When to consult or refer
Group 2: Medications FDA-approved for youth, typically prescribed by specialists but often monitored in the primary care setting: antipsychotics, mood stabilizers, antidepressants, anxiolytics, and sleep aids. To support primary care clinician's collaborative role, usage rationales, efficacy data, and adverse effect profiles are specified for all of these agents.
Group 3: Medications not FDA-approved for youth that primary care clinicians will likely encounter. To support primary care clinician's collaborative role, efficacy data and adverse effect profiles are specified for these agents.
Proven, practice-focused guidance
Hands-on help spanning the therapeutic process:
Assessing for common disorders
Assessing for psychiatric comorbidities
Identifying medication needs
Informed consent
Monitoring patient progress
Managing side effects
Managing multiple medications
Stopping or changing medications
Pediatric Psychopharmacology For Primary CarePediatric Psychopharmacology For Primary Care
Pediatric Psychopharmacology For Primary CarePediatric Psychopharmacology For Primary Care
DOWNLOAD
(Buy premium account for maximum speed and resuming ability)
http://nitroflare.com/view/EC0C951B12D2FF1/90fzc.P.P.F.P.C.rar
http://rapidgator.net/file/dc21bba07a03af61e924fc05d14c3a8d/90fzc.P.P.F.P.C.rar
http://uploaded.net/file/okprb9dw/90fzc.P.P.F.P.C.rar
Pediatric Psychopharmacology For Primary Care by Dr. Mark A Riddle M.D.
2015 | ISBN: 1581102755 | English | 225 pages | PDF | 5 MB
Confidently prescribe, monitor, and manage medications for childhood mental health disorders.
This game-changing resource from the American Academy of Pediatrics (AAP) arms you with a unique strategic approach-plus practice-tested, condition-specific treatment recommendations.
Free bonus digital tool! Get instant answers on specific conditions and medications from your desktop or mobile device!
Evidence-based conceptual framework
A clear, straightforward methodology-based on current research and clinical experience-defines discrete levels of psychotropic agents and spells out level-specific roles and responsibilities.
Group 1:Medications FDA-approved for youth for ADHD, anxiety, and depression-disorders for which pediatric primary care providers commonly initiate treatment and assume prescribing and monitoring responsibilities.
Administration and management information for each drug agent includes:
Rationale for use
Evidence supporting efficacy and safety
Initial dosing and subsequent adjustments
Measuring therapeutic success
When to consult or refer
Group 2: Medications FDA-approved for youth, typically prescribed by specialists but often monitored in the primary care setting: antipsychotics, mood stabilizers, antidepressants, anxiolytics, and sleep aids. To support primary care clinician's collaborative role, usage rationales, efficacy data, and adverse effect profiles are specified for all of these agents.
Group 3: Medications not FDA-approved for youth that primary care clinicians will likely encounter. To support primary care clinician's collaborative role, efficacy data and adverse effect profiles are specified for these agents.
Proven, practice-focused guidance
Hands-on help spanning the therapeutic process:
Assessing for common disorders
Assessing for psychiatric comorbidities
Identifying medication needs
Informed consent
Monitoring patient progress
Managing side effects
Managing multiple medications
Stopping or changing medications
Pediatric Psychopharmacology For Primary CarePediatric Psychopharmacology For Primary Care
Pediatric Psychopharmacology For Primary CarePediatric Psychopharmacology For Primary Care
DOWNLOAD
(Buy premium account for maximum speed and resuming ability)
http://nitroflare.com/view/EC0C951B12D2FF1/90fzc.P.P.F.P.C.rar
http://rapidgator.net/file/dc21bba07a03af61e924fc05d14c3a8d/90fzc.P.P.F.P.C.rar
http://uploaded.net/file/okprb9dw/90fzc.P.P.F.P.C.rar